Idorsia
Julien Gander is an accomplished legal professional with extensive experience in corporate law and risk management. Currently serving as Group General Counsel at Idorsia Pharmaceuticals Ltd since November 2022, Julien has previously held significant roles at Molecular Partners AG in Zurich as General Counsel and Vice President Legal from July 2016. Prior experience includes serving as Director of Legal & Group Risk Management at Lonza, where Julien also acted as Secretary of the Board of Directors and Senior Legal Counsel from May 2012 to May 2016. Early career experiences include positions at Homburger and the Swiss Competition Commission, focusing on M&A and corporate law. Julien's educational background consists of an LL.M. from the University of Cambridge, Bar Examination qualifications from Canton of Bern, and an LL.M. from the University of Fribourg, along with studies at the University of Tübingen.
Idorsia
4 followers
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.